| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 484.880 | 800.079 | 1.493.883 | 2.309.710 | 3.747.375 | 4.110.110 | 4.858.484 |
| Total Income - EUR | - | - | 1 | 486.014 | 800.360 | 1.494.288 | 2.309.913 | 3.751.044 | 4.114.507 | 4.863.194 |
| Total Expenses - EUR | - | - | 26.363 | 493.176 | 729.830 | 1.336.137 | 2.049.914 | 3.281.763 | 3.760.731 | 4.657.307 |
| Gross Profit/Loss - EUR | - | - | -26.362 | -7.162 | 70.531 | 158.151 | 259.999 | 469.282 | 353.776 | 205.887 |
| Net Profit/Loss - EUR | - | - | -26.362 | -7.912 | 58.960 | 135.753 | 226.266 | 410.920 | 310.189 | 179.875 |
| Employees | - | - | 1 | 2 | 2 | 2 | 2 | 4 | 5 | 5 |
Check the financial reports for the company - Genco Pharmaceuticals Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 9.302 | 2.195 | 25.732 | 26.631 | 21.657 | 52.370 | 34.150 | 18.791 |
| Current Assets | - | - | 3.671 | 88.963 | 251.864 | 657.572 | 662.531 | 981.431 | 1.751.981 | 1.783.129 |
| Inventories | - | - | 0 | 3.528 | 219.551 | 312.272 | 329.983 | 438.990 | 832.161 | 780.635 |
| Receivables | - | - | 1.541 | 6.601 | 9.282 | 206.416 | 320.623 | 513.880 | 918.433 | 980.442 |
| Cash | - | - | 2.131 | 78.834 | 23.031 | 138.885 | 11.925 | 28.561 | 1.387 | 22.053 |
| Shareholders Funds | - | - | -16.511 | -24.120 | 35.308 | 170.391 | 368.106 | 647.745 | 955.970 | 1.021.879 |
| Social Capital | - | - | 9.851 | 9.670 | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | 9.046 |
| Debts | - | - | 29.484 | 115.418 | 242.411 | 513.894 | 330.952 | 401.415 | 853.704 | 802.311 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Genco Pharmaceuticals Srl